首页|氟维司群抑制血小板功能的研究

氟维司群抑制血小板功能的研究

扫码查看
目的 探究氟维司群对血小板功能的影响及相关机制.方法 将不同浓度的氟维司群(0.1、1和10 µmol/L)及溶剂对照(0.25%二甲基亚砜DMSO)分别与人血小板在体外进行共孵育,然后用聚集仪检测其对凝血酶、胶原、U46619刺激的血小板聚集及ATP释放的影响;流式细胞术检测血小板表面P-选择素表达和整合素αⅡbβ3活化情况;荧光显微镜观察氟维司群对纤维蛋白原表面血小板铺展的影响;蛋白免疫印迹检测AKT Ser473和PKC蛋白的磷酸化水平.结果 氟维司群能够抑制凝血酶、胶原、U46619诱导的血小板聚集和ATP释放,抑制血小板P-选择素表达和整合素αⅡbβ3活化和血小板铺展,降低AKT Ser473和PKC的磷酸化水平.结论 氟维司群抑制血小板聚集、释放、铺展功能,其机制与调控AKT和PKC蛋白磷酸化水平有关,可作为潜在的抗血小板药物.
Study on the inhibition of platelet function by fulvestrant
Objective To investigate the effect of fulvestrant on platelet function and its related mechanism.Methods Different concentrations of fulvestrant(0.1,1 and 10 µmol/L)and solvent control(0.25%dimethyl sulfoxide(DMSO))were co-incubated with human platelets in vitro,and then the effects of fulvestrant on platelet aggregation and ATP release stimulated by thrombin,collagen and U46619 were detected by aggregometer.The expression of P-selectin on the platelet surface and the activation of integrin αⅡbβ3 were detected by flow cytometry.The effect of fulvestrant on platelet spreading on the fibrinogen surface was observed by fluorescence microscopy.The phosphorylation levels of AKT Ser473 and PKC proteins were detected by western blotting.Results Fulvestrant could inhibit platelet aggregation and ATP release induced by thrombin,collagen and U46619,inhibit the expression of P-selectin,integrin αⅡbβ3 activation and platelet spreading,and reduce the phosphorylation levels of AKT Ser473 and PKC.Conclusion Fulvestrant inhibits platelet aggregation,release and spreading,and its mechanism is related to the regulation of AKT and PKC protein phosphorylation levels.It can be used as a potential antiplatelet drug.

FulvestrantPlatelet activationAKT phosphorylationPKC pathway

马如越、赵丽丽、杨梦楠、张蕾、赵瑞珩、戴克胜

展开 >

苏州大学附属苏州九院(苏州市第九人民医院),苏州 215299

苏州大学附属第一医院,苏州大学唐仲英医学研究院,江苏省血液研究所,苏州 215006

氟维司群 血小板活化 AKT磷酸化 PKC通路

国家自然科学基金重点国际合作项目国家自然科学基金项目苏州市吴江区卫健委科教兴卫项目苏州市第九人民医院院内科研课题项目

8182010800381770117WWK202201YK202202

2024

血栓与止血学
广州医学院第二附属医院

血栓与止血学

影响因子:0.981
ISSN:1009-6213
年,卷(期):2024.30(4)